Back to Search
MATTHEW MORRIS, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1801356407Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
1801356407(NY)
Research & Publications (20)
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.
PMID 19213669·Clin Genitourin Cancer·2009
8-other
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
PMID 19364960·J Clin Oncol·2009
3-trial
Features of nephrogenic systemic fibrosis on radiology examinations.
PMID 19542396·AJR Am J Roentgenol·2009
6-review
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
PMID 19375217·Eur Urol·2009
3-trial
Mistaken identity: activating conservative political identities induces "conservative" financial decisions.
PMID 19076488·Psychol Sci·2008
8-other
Randomized, controlled trials as minimal risk: an ethical analysis.
PMID 17255879·Crit Care Med·2007
8-other
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.
PMID 17473203·Clin Cancer Res·2007
3-trial
A paradigm for inpatient resuscitation research with an exception from informed consent.
PMID 16915111·Crit Care Med·2006
8-other
Paclitaxel and carboplatin versus mitoxantrone: lessons of an underpowered study.
PMID 17019430·Nat Clin Pract Oncol·2006
8-other
Flavonoid-drug interactions: effects of flavonoids on ABC transporters.
PMID 16455109·Life Sci·2006
6-review
An ethical analysis of exception from informed consent regulations.
PMID 16264082·Acad Emerg Med·2005
8-other
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer.
PMID 15869719·Curr Urol Rep·2005
6-review
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.
PMID 16243819·Clin Cancer Res·2005
3-trial
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer.
PMID 15066234·Curr Oncol Rep·2004
6-review
Survival outcomes after extracorporeal cardiopulmonary resuscitation instituted during active chest compressions following refractory in-hospital pediatric cardiac arrest.
PMID 15329159·Pediatr Crit Care Med·2004
4-observational
Gender differences in the membrane transport of endogenous and exogenous compounds.
PMID 12773628·Pharmacol Rev·2003
6-review
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center.
PMID 12850524·Crit Rev Oncol Hematol·2003
6-review
Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies.
PMID 12031864·Surg Oncol·2002
6-review
Molecular mechanisms in renal and intestinal sulfate (re)absorption.
PMID 11331932·J Membr Biol·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 999 FRANKLIN AVE
GARDEN CITY, NY 11530 - Phone
- (516) 742-3404
Quick Facts
- NPI
- 1801356407
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile